Share Share this content Opens in a new window Opens in a new window Opens in a new window Opens in a new window OPA's Submission to OCP on DPRA Proposed Amendments You may be interested in Nirmatrelvir/Ritonavir (Paxlovid) Prescribing December 12, 2022 Post category: Advocacy Virtual Townhall – Symptomatic COVID-19 Testing in Pharmacies November 26, 2021 Post category: Advocacy Ontario Pharmacists Association Responds to Ontario’s Fall Economic Statement November 4, 2021 Post category: Advocacy OPA’s COVID-19 Advocacy Initiatives November 10, 2020 Post category: Advocacy
Virtual Townhall – Symptomatic COVID-19 Testing in Pharmacies November 26, 2021 Post category: Advocacy
Ontario Pharmacists Association Responds to Ontario’s Fall Economic Statement November 4, 2021 Post category: Advocacy
